Mereo BioPharma Group plc (NASDAQ:MREO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Deepika Pakianathan Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Theravance Biopharma, Inc. (Director · Since at least Jul 1, 2020); Karyopharm Therapeutics Inc. (Director · Since at least Nov 5, 2013); Pardes Biosciences Inc (Director · Feb 16, 2021 – Dec 23, 2021 · Past); Disc Medicine, Inc. (Director · Aug 11, 2020 – Aug 11, 2020 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Jan 27, 2023 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – May 23, 2018 · Past); OncoMed Pharmaceuticals Inc (Director · Jul 17, 2013 – Apr 23, 2019 · Past); Alexza Pharmaceuticals Inc (Director · Mar 8, 2006 – Jun 21, 2016 · Past) | Director · Since at least Jan 1, 2024 |
| Annalisa Jenkins Other companies: Skye Bioscience, Inc. (Director · Since at least Feb 29, 2024); COMPASS Pathways Plc (Director · Since at least Jan 1, 2022); Serina Therapeutics, Inc. (Director · Nov 27, 2018 – Jun 21, 2021 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 6, 2023 · Past); Dimension Therapeutics (President and CEO, Director · Oct 21, 2015 – Nov 7, 2017 · Past); Ardelyx, Inc. (Director · Apr 20, 2015 – Jun 13, 2019 · Past) | Director · Since at least Jan 1, 2024 |
| Denise Pollard-Knight Other companies: Elanco Animal Health Incorporated (Director · Since at least Mar 11, 2019); Albireo Pharma Inc (Director · Nov 3, 2016 – Jun 16, 2017 · Past); OncoMed Pharmaceuticals Inc (Director · Jul 17, 2013 – Jun 22, 2018 · Past); Idenix Pharmaceuticals Inc (Director · Jun 14, 2006 – Aug 5, 2014 · Past) | Chief Executive Officer, Director · Since at least Jan 1, 2024 |
| Jeremy Bender Other companies: Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Aura Biosciences, Inc. (Director · Since at least Jul 7, 2026); Day One Biopharmaceuticals Inc (CHIEF EXECUTIVE OFFICER, Director · Since at least May 26, 2021); Fusion Pharmaceuticals Inc (Director · Oct 16, 2023 – Jun 4, 2024 · Past) | Non-Executive Director · Since at least Jan 1, 2024 |
| Michael Wyzga Other companies: X4 Pharmaceuticals, Inc. (Director · Since at least Jun 9, 2025); Tvardi Therapeutics, Inc. (Board Member · Since at least Apr 15, 2025); Kineta Inc. (See Remarks · Aug 16, 2021 – Dec 2, 2022 · Past) | Director · Since at least Feb 26, 2026 |
| Deepa Pakianathan Other companies: Freenome, Inc. (Chief Executive Officer, a stealth Biotech Company · Since at least Nov 5, 2026); Perceptive Capital Solutions Corp (Chief Executive Officer · Since at least Nov 5, 2026) | Non-Executive Director · Since at least Nov 5, 2026 |
| Marc Yoskowitz Other companies: Mallinckrodt Inc (Director · Since at least Jul 31, 2025); Hospira Inc (SVP, Strategy & Corporate Dev · Aug 13, 2014 – Sep 3, 2015 · Past) | Non-Executive Director · Since at least Jan 1, 2024 |
| John Lewicki Other companies: OncoMed Pharmaceuticals Inc (President and CEO, Director · Jul 17, 2013 – Apr 23, 2019 · Past) | Chief Scientific Officer · Since at least Jan 1, 2024 |
| Justin H. Roberts Other companies: TherapeuticsMD, Inc. (Board Member · Since at least Aug 23, 2022) | Non-Executive Director · Since at least Jan 1, 2024 |
| Pierre Jacquet Other companies: EXACT Sciences Corporation (Director · Jun 9, 2022 – Jun 8, 2023 · Past) | Non-Executive Director · Since at least Jan 1, 2024 |
| Alexandra Hughes-Wilson | See Remarks · Since at least Jan 1, 2024 |
| Anders Ekblom | Non-Executive Director · Since at least Jan 1, 2024 |
| Bal Lally | Vice President, Head of HR · Since at least Nov 4, 2026 |
| Bharti Navsariwala | Vice President, Head of Regulatory Affairs · Since at least Nov 4, 2026 |
| Bo Kara | Senior Vice President, Head of Pharmaceutical Development · Since at least Nov 4, 2026 |
| Charles Sermon | General Counsel and Business Development · Since at least Jan 1, 2024 |
| Christine Fox | Chief Financial Officer · Since at least Jan 1, 2024 |
| Daniel Shames | Non-Executive Director · Since at least Jan 1, 2024 |
| Denise Scots-Knight | Chief Executive Officer · Since at least Mar 19, 2026 |
| Jackie Parkin | Senior Vice President, Therapeutic Head · Since at least Nov 4, 2026 |
| Ogün Sazova | Vice President, Clinical Development and Medical Affairs · Since at least Nov 4, 2026 |
| Wills Hughes-Wilson | Chief Patient Access and Commercial Planning · Since at least Nov 4, 2026 |